Clarithromycin, montelukast, and pentoxifylline combination treatment ameliorates experimental neonatal hyperoxic lung injury

DEMİR, KORCAN; KUMRAL, ABDULLAH; DUMAN, NURAY; SARIOĞLU, SÜLEN; Yilmaz, OSMAN; Yesilirmak, Didem; Kargi, Aydanur; ÖZKAN, HASAN

doi:10.1080/14767050802045715

Clarithromycin, montelukast, and pentoxifylline combination treatment ameliorates experimental neonatal hyperoxic lung injury

DEMİR K., KUMRAL A., DUMAN N., SARIOĞLU S., Yilmaz O., Yesilirmak D. C., ...Daha Fazla

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, cilt.21, sa.6, ss.407-413, 2008 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 21 Sayı: 6
Basım Tarihi: 2008
Doi Numarası: 10.1080/14767050802045715
Dergi Adı: JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.407-413
Anahtar Kelimeler: hyperoxic lung injury, bronchopulmonary dysplasia, newborn, clarithromycin, montelukast, pentoxifylline
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective. We aimed to assess the efficiency of clarithromycin, montelukast, and pentoxifylline treatments, alone and in combination, in reducing hyperoxic lung injury at the histopathologic level.